Using univariate Cox proportional hazard analysis on 3826 breast cancer samples, we demonstrated that CENPI overexpression is a strong marker for poor patient prognosis (p=6.13×10-10) (Table 1). This evidence concerns the gene CENPI and breast carcinoma.